Loading…

Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial

To investigate the effect of intravenous tranexamic acid administered prior to external dacryocystorhinostomy (DCR) surgery to decrease intraoperative bleeding under general anesthesia. This was a double-blinded randomized placebo-controlled trial. A total of 70 patients (35 intervention and 35 cont...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ophthalmic & vision research 2024-07, Vol.19 (3), p.340-346
Main Authors: Sharifi, Mohammad, Yaser Kiarudi, Mohammad, Gholamhoseinpour-Omran, Samaneh, Alipour, Mohammad, Bakhtiari, Elham
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c348t-58ffb37f1d2807d2af5c13d315b346900ead5da230bfed44a29de607868cc7aa3
container_end_page 346
container_issue 3
container_start_page 340
container_title Journal of ophthalmic & vision research
container_volume 19
creator Sharifi, Mohammad
Yaser Kiarudi, Mohammad
Gholamhoseinpour-Omran, Samaneh
Alipour, Mohammad
Bakhtiari, Elham
description To investigate the effect of intravenous tranexamic acid administered prior to external dacryocystorhinostomy (DCR) surgery to decrease intraoperative bleeding under general anesthesia. This was a double-blinded randomized placebo-controlled trial. A total of 70 patients (35 intervention and 35 control) with nasolacrimal duct obstruction (NLDO) who were selected for DCR surgery between September 2021 and September 2022 were included. After clinical examinations and laboratory tests, patients were randomly classified into intervention and control groups. The intervention group received 10 mg/kg intravenous tranexamic acid to a maximum dose of 1 gr 30 minutes before the surgery. Controls received normal saline solution as a placebo. The amount of intraoperative bleeding and surgical time were compared between the two groups. The intervention group included 21 men (60%) and 14 women (40%), while the control group included 19 men (54.3%) and 16 women (45.7%). The mean ages of the participants were 55.46 10.8 years and 58.06 11.28 years in the intervention and control groups, respectively. A significant difference was observed between the two groups in the surgical time analysis (control group: 37.74 9.52 minutes vs intervention: 26.03 10.5 minutes; P 0.001). Additionally, there was a significant difference in the bleeding volume between the intervention (70.66 48.19 ml) and control (47.74 60 ml) groups (P 0.001). Intravenous tranexamic acid administration before the DCR procedure can successfully control bleeding during the surgery.
doi_str_mv 10.18502/jovr.v19i3.13947
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0cb90e41d56c4dc5a422e141cadcb1f9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0cb90e41d56c4dc5a422e141cadcb1f9</doaj_id><sourcerecordid>3112528003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-58ffb37f1d2807d2af5c13d315b346900ead5da230bfed44a29de607868cc7aa3</originalsourceid><addsrcrecordid>eNpVkstuEzEUhkcIREvhAdggL9kk-DYXs0FpKCVSJSQUJHbWGftM4shjF88kangJXhnnQkVXv2X_57N9zl8Ubxmdsqak_MMm7tJ0x5QTUyaUrJ8Vl5zSZiI4__n8vOaU0Yvi1TBsKK2qSjYviwuhRKlKUV0WfxZhTLDDELcDWSYI-AC9M2RmnCVdTGQesyF6Ejty7RGtCytit-kgNw8jpgCefAaT9tHshzGmtQsxa78n22AxkVsMmLJnFnAY1zg4-Ehm5DsEG3v3Gy2ZexecyY5lcuBfFy868AO-OetV8ePLzXL-dXL37XYxn91NjJDNOCmbrmtF3THLG1pbDl1pmLCCla2QlaIUwZYWuKBth1ZK4MpiReumaoypAcRVsThxbYSNvk-uh7TXEZw-bsS00pBGZzxqalpFUTJbVkZaU4LkHJlkBqxpWacy69OJdb9te7QGDy31T6BPT4Jb61XcacakFEpVmfD-TEjx1zY3SvduMOh9nkcejBaM8TL_lIpsZSerSXEYEnaP9zCqj6nQh1ToYyr0MRW55t3_D3ys-BcD8RcNlLmT</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3112528003</pqid></control><display><type>article</type><title>Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial</title><source>PubMed Central (Open access)</source><creator>Sharifi, Mohammad ; Yaser Kiarudi, Mohammad ; Gholamhoseinpour-Omran, Samaneh ; Alipour, Mohammad ; Bakhtiari, Elham</creator><creatorcontrib>Sharifi, Mohammad ; Yaser Kiarudi, Mohammad ; Gholamhoseinpour-Omran, Samaneh ; Alipour, Mohammad ; Bakhtiari, Elham</creatorcontrib><description>To investigate the effect of intravenous tranexamic acid administered prior to external dacryocystorhinostomy (DCR) surgery to decrease intraoperative bleeding under general anesthesia. This was a double-blinded randomized placebo-controlled trial. A total of 70 patients (35 intervention and 35 control) with nasolacrimal duct obstruction (NLDO) who were selected for DCR surgery between September 2021 and September 2022 were included. After clinical examinations and laboratory tests, patients were randomly classified into intervention and control groups. The intervention group received 10 mg/kg intravenous tranexamic acid to a maximum dose of 1 gr 30 minutes before the surgery. Controls received normal saline solution as a placebo. The amount of intraoperative bleeding and surgical time were compared between the two groups. The intervention group included 21 men (60%) and 14 women (40%), while the control group included 19 men (54.3%) and 16 women (45.7%). The mean ages of the participants were 55.46 10.8 years and 58.06 11.28 years in the intervention and control groups, respectively. A significant difference was observed between the two groups in the surgical time analysis (control group: 37.74 9.52 minutes vs intervention: 26.03 10.5 minutes; P 0.001). Additionally, there was a significant difference in the bleeding volume between the intervention (70.66 48.19 ml) and control (47.74 60 ml) groups (P 0.001). Intravenous tranexamic acid administration before the DCR procedure can successfully control bleeding during the surgery.</description><identifier>ISSN: 2008-2010</identifier><identifier>EISSN: 2008-322X</identifier><identifier>DOI: 10.18502/jovr.v19i3.13947</identifier><identifier>PMID: 39359536</identifier><language>eng</language><publisher>United Arab Emirates: PUBLISHED BY KNOWLEDGE E</publisher><subject>external dacryocystorhinostomy ; intraoperative hemorrhage ; intravenous tranexamic acid ; Original</subject><ispartof>Journal of ophthalmic &amp; vision research, 2024-07, Vol.19 (3), p.340-346</ispartof><rights>Copyright © 2024 Sharifi et al.</rights><rights>Copyright © 2024 Sharifi et al. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-58ffb37f1d2807d2af5c13d315b346900ead5da230bfed44a29de607868cc7aa3</cites><orcidid>0000-0002-0973-1366</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443996/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443996/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39359536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharifi, Mohammad</creatorcontrib><creatorcontrib>Yaser Kiarudi, Mohammad</creatorcontrib><creatorcontrib>Gholamhoseinpour-Omran, Samaneh</creatorcontrib><creatorcontrib>Alipour, Mohammad</creatorcontrib><creatorcontrib>Bakhtiari, Elham</creatorcontrib><title>Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial</title><title>Journal of ophthalmic &amp; vision research</title><addtitle>J Ophthalmic Vis Res</addtitle><description>To investigate the effect of intravenous tranexamic acid administered prior to external dacryocystorhinostomy (DCR) surgery to decrease intraoperative bleeding under general anesthesia. This was a double-blinded randomized placebo-controlled trial. A total of 70 patients (35 intervention and 35 control) with nasolacrimal duct obstruction (NLDO) who were selected for DCR surgery between September 2021 and September 2022 were included. After clinical examinations and laboratory tests, patients were randomly classified into intervention and control groups. The intervention group received 10 mg/kg intravenous tranexamic acid to a maximum dose of 1 gr 30 minutes before the surgery. Controls received normal saline solution as a placebo. The amount of intraoperative bleeding and surgical time were compared between the two groups. The intervention group included 21 men (60%) and 14 women (40%), while the control group included 19 men (54.3%) and 16 women (45.7%). The mean ages of the participants were 55.46 10.8 years and 58.06 11.28 years in the intervention and control groups, respectively. A significant difference was observed between the two groups in the surgical time analysis (control group: 37.74 9.52 minutes vs intervention: 26.03 10.5 minutes; P 0.001). Additionally, there was a significant difference in the bleeding volume between the intervention (70.66 48.19 ml) and control (47.74 60 ml) groups (P 0.001). Intravenous tranexamic acid administration before the DCR procedure can successfully control bleeding during the surgery.</description><subject>external dacryocystorhinostomy</subject><subject>intraoperative hemorrhage</subject><subject>intravenous tranexamic acid</subject><subject>Original</subject><issn>2008-2010</issn><issn>2008-322X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkstuEzEUhkcIREvhAdggL9kk-DYXs0FpKCVSJSQUJHbWGftM4shjF88kangJXhnnQkVXv2X_57N9zl8Ubxmdsqak_MMm7tJ0x5QTUyaUrJ8Vl5zSZiI4__n8vOaU0Yvi1TBsKK2qSjYviwuhRKlKUV0WfxZhTLDDELcDWSYI-AC9M2RmnCVdTGQesyF6Ejty7RGtCytit-kgNw8jpgCefAaT9tHshzGmtQsxa78n22AxkVsMmLJnFnAY1zg4-Ehm5DsEG3v3Gy2ZexecyY5lcuBfFy868AO-OetV8ePLzXL-dXL37XYxn91NjJDNOCmbrmtF3THLG1pbDl1pmLCCla2QlaIUwZYWuKBth1ZK4MpiReumaoypAcRVsThxbYSNvk-uh7TXEZw-bsS00pBGZzxqalpFUTJbVkZaU4LkHJlkBqxpWacy69OJdb9te7QGDy31T6BPT4Jb61XcacakFEpVmfD-TEjx1zY3SvduMOh9nkcejBaM8TL_lIpsZSerSXEYEnaP9zCqj6nQh1ToYyr0MRW55t3_D3ys-BcD8RcNlLmT</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Sharifi, Mohammad</creator><creator>Yaser Kiarudi, Mohammad</creator><creator>Gholamhoseinpour-Omran, Samaneh</creator><creator>Alipour, Mohammad</creator><creator>Bakhtiari, Elham</creator><general>PUBLISHED BY KNOWLEDGE E</general><general>Knowledge E</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0973-1366</orcidid></search><sort><creationdate>20240701</creationdate><title>Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial</title><author>Sharifi, Mohammad ; Yaser Kiarudi, Mohammad ; Gholamhoseinpour-Omran, Samaneh ; Alipour, Mohammad ; Bakhtiari, Elham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-58ffb37f1d2807d2af5c13d315b346900ead5da230bfed44a29de607868cc7aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>external dacryocystorhinostomy</topic><topic>intraoperative hemorrhage</topic><topic>intravenous tranexamic acid</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharifi, Mohammad</creatorcontrib><creatorcontrib>Yaser Kiarudi, Mohammad</creatorcontrib><creatorcontrib>Gholamhoseinpour-Omran, Samaneh</creatorcontrib><creatorcontrib>Alipour, Mohammad</creatorcontrib><creatorcontrib>Bakhtiari, Elham</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of ophthalmic &amp; vision research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharifi, Mohammad</au><au>Yaser Kiarudi, Mohammad</au><au>Gholamhoseinpour-Omran, Samaneh</au><au>Alipour, Mohammad</au><au>Bakhtiari, Elham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial</atitle><jtitle>Journal of ophthalmic &amp; vision research</jtitle><addtitle>J Ophthalmic Vis Res</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>19</volume><issue>3</issue><spage>340</spage><epage>346</epage><pages>340-346</pages><issn>2008-2010</issn><eissn>2008-322X</eissn><abstract>To investigate the effect of intravenous tranexamic acid administered prior to external dacryocystorhinostomy (DCR) surgery to decrease intraoperative bleeding under general anesthesia. This was a double-blinded randomized placebo-controlled trial. A total of 70 patients (35 intervention and 35 control) with nasolacrimal duct obstruction (NLDO) who were selected for DCR surgery between September 2021 and September 2022 were included. After clinical examinations and laboratory tests, patients were randomly classified into intervention and control groups. The intervention group received 10 mg/kg intravenous tranexamic acid to a maximum dose of 1 gr 30 minutes before the surgery. Controls received normal saline solution as a placebo. The amount of intraoperative bleeding and surgical time were compared between the two groups. The intervention group included 21 men (60%) and 14 women (40%), while the control group included 19 men (54.3%) and 16 women (45.7%). The mean ages of the participants were 55.46 10.8 years and 58.06 11.28 years in the intervention and control groups, respectively. A significant difference was observed between the two groups in the surgical time analysis (control group: 37.74 9.52 minutes vs intervention: 26.03 10.5 minutes; P 0.001). Additionally, there was a significant difference in the bleeding volume between the intervention (70.66 48.19 ml) and control (47.74 60 ml) groups (P 0.001). Intravenous tranexamic acid administration before the DCR procedure can successfully control bleeding during the surgery.</abstract><cop>United Arab Emirates</cop><pub>PUBLISHED BY KNOWLEDGE E</pub><pmid>39359536</pmid><doi>10.18502/jovr.v19i3.13947</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-0973-1366</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2008-2010
ispartof Journal of ophthalmic & vision research, 2024-07, Vol.19 (3), p.340-346
issn 2008-2010
2008-322X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0cb90e41d56c4dc5a422e141cadcb1f9
source PubMed Central (Open access)
subjects external dacryocystorhinostomy
intraoperative hemorrhage
intravenous tranexamic acid
Original
title Intravenous Tranexamic Acid for Control of Bleeding during External Dacryocystorhinostomy under General Anesthesia: A Randomized Clinical Trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A56%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20Tranexamic%20Acid%20for%20Control%20of%20Bleeding%20during%20External%20Dacryocystorhinostomy%20under%20General%20Anesthesia:%20A%20Randomized%20Clinical%20Trial&rft.jtitle=Journal%20of%20ophthalmic%20&%20vision%20research&rft.au=Sharifi,%20Mohammad&rft.date=2024-07-01&rft.volume=19&rft.issue=3&rft.spage=340&rft.epage=346&rft.pages=340-346&rft.issn=2008-2010&rft.eissn=2008-322X&rft_id=info:doi/10.18502/jovr.v19i3.13947&rft_dat=%3Cproquest_doaj_%3E3112528003%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-58ffb37f1d2807d2af5c13d315b346900ead5da230bfed44a29de607868cc7aa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3112528003&rft_id=info:pmid/39359536&rfr_iscdi=true